Skip to main content

UBS Group AG

Position in SRZN — Surrozen, Inc./DE

CIK 1610520 ZURICH, V8

Position in SRZN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$758,492
+$139,568 QoQ
Shares Held
32,463
+35.6% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 70 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SRZN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. SRZN ranks #276 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SRZN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 SRZNW 3,234
2026-06-30 $758,492 29,229
2026-03-31 SRZNW 2,701
2026-03-31 $618,924 21,247
2025-12-31 SRZNW 1,600
2025-12-31 $1,333 59
2025-09-30 SRZNW 1,389
2025-06-30 SRZNW 1,440
2025-06-30 $2,315 259
2025-03-31 SRZNW 2,754
2025-03-31 $2,297 197
2024-12-31 $459 32
2024-06-30 $131,695 12,027
2024-03-31 SRZNW 3
2023-12-31 SRZNW 9,100
2023-12-31 $432 46
2023-09-30 $2,332 4,761
2023-03-31 $9,180 15,250
2022-12-31 SRZNW 509
2022-12-31 $1,091 1,875
2022-09-30 $1,589 787
2021-06-30 CHFW 1,592
2021-03-31 CHFW 3,512